Walmart reaches settlement with US Justice Department over opioid litigation

Walmart and the US Justice Department have concluded litigation over the company's role in the opioid epidemic, both parties announced without revealing specific settlement details.

The resolution represents the latest in a series of major agreements between government authorities and large corporations accused of contributing to widespread opioid addiction and overdose deaths across the United States. Previous settlements have involved pharmaceutical manufacturers, distributors, and pharmacy chains.

Neither Walmart nor the Justice Department disclosed the financial terms of the agreement or other conditions attached to the settlement. The retail sector has faced increasing scrutiny regarding the dispensing of prescription opioids through its pharmacy operations.

The opioid crisis has claimed hundreds of thousands of American lives over the past two decades, prompting federal investigations, lawsuits, and regulatory action against key players in the pharmaceutical supply chain. Government officials have sought to secure settlements that address both past liabilities and establish standards for future operations.